Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04020913 · ClinicalTrials.gov registry record
Skeletal Muscle Effects of GH in Boys
A clinical trial, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- 45
- Enrollment target
NCT04020913: Completed study, sponsored by Nemours Children's Clinic.
NCT04020913 is a clinical trial that has completed, run by Nemours Children's Clinic. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04020913 has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of the study is to measure the functional effects of recombinant GH in skeletal muscle, in addition to growth promotion, in short prepubertal boys with either growth hormone deficiency or idiopathic short stature. Patients will be similarly short. The investigators will also compare these values in the short stature cohort to those obtained in testing performed in normally growing age-matched healthy control boys not on GH. The group on GH will be studied before and after 6 and 12 months of GH treatment.
Primary Outcome
Upper and lower body muscle strength will be assessed using a handheld dynamometer for manual muscle testing of peak force
Interventions
- DRUG Somatropin injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-07-22 |
| Est. Completion | 2025-10-30 |
What the finished NCT04020913 record still lists
NCT04020913 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Somatropin injection is the first listed.
NCT04020913 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04020913 about?
NCT04020913 is a clinical study titled "Skeletal Muscle Effects of GH in Boys". The purpose of the study is to measure the functional effects of recombinant GH in skeletal muscle, in addition to growth promotion, in short prepubertal boys with either growth hormone deficiency or idiopathic short stature. Patients will be similarly short. The investigators will also compare thes...
What is the current status of trial NCT04020913?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2019-07-22. Estimated completion is 2025-10-30.
What interventions are being tested in trial NCT04020913?
The interventions under investigation include: Somatropin injection (DRUG).
Who is sponsoring clinical trial NCT04020913?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI